Mankind Pharma Ltd IPO

The company is subject to extensive government regulations which are also subject to change. If the company fail to comply with the applicable regulations prescribed by the governments and the relevant regulatory agencies, its business, financial condition, cash flows and results of operations will be adversely affected.

The company is required to obtain, maintain or renew its statutory and regulatory approvals, licenses, and registrations to operate its business.

Any disruption, slowdown or shutdown in its manufacturing or R&D operations could adversely affect its business, financial condition, cash flows and results of operations.

The company inability to accurately forecast demand for its products and manage the company inventory may have an adverse effect on its business, financial condition, cash flows and results of operations.

Any failure to maintain and enhance, or any damage to, its brands, product image or reputation could adversely affect the market recognition of, and trust in, the company products.

Any delay, interruption or reduction in the supply of its raw materials or finished formulations from its third-party suppliers and manufacturers, or an increase in the costs of such raw materials and finished formulations, may adversely impact the pricing and supply of its products and have an adverse effect on the company business, financial condition, cash flows and results of operations.

If the company do not successfully develop or commercialize new products in a timely manner, or if the products that the company commercialize do not perform as expected, its business, results of operations and financial condition may be adversely affected.

The availability of counterfeit drugs, such as drugs passed off by others as its products, could adversely affect the company goodwill and results of operations.

Its inability to successfully implement the company business plan, expansion and growth strategies could have an adverse effect on its business, financial condition, cash flows and results of operations.

Any problems in its quality control or manufacturing processes may damage the company reputation, subject us to regulatory action and expose it to litigation or other liabilities.